Concepedia

Author

Sophie Bouchat

Université Libre de Bruxelles

Also Known As

Bouchat, S, Bouchat, Sophie, S. Bouchat, Sophie Bouchat

38

Publications

1.2K

Citations

13

H-Index

13

Concepts

All Affiliations

Université Libre de BruxellesUniversité de StrasbourgAssistance Publique – Hôpitaux de ParisHôpital Necker-Enfants MaladesCentre Hospitalier Universitaire de Saint-Pierre
SB

About

Sophie Bouchat is an author at Université Libre de Bruxelles specializing in immunology, cell biology, and tumor immunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

279

2

Cell Biology

1

1

279

3

Immunology

1

1

279

4

Pharmacology

1

1

279

5

Cell Development

1

1

279

Sophie Bouchat

×

11

Publications

781

Citations

11

H-Index

YearCitations

An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression

Gilles Darcis, Anna Kula, Sophie Bouchat,

PLoS Pathogens

2015

279

Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients

Sophie Bouchat, Jean-Stéphane Gatot, Kabamba Kabeya,

AIDS

2012

145

Immunity drives <i>TET1</i> regulation in cancer through NF-κB

Évelyne Collignon, Annalisa Canale, Clémence Al Wardi,

Science Advances

2018

88

Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates <scp>HIV</scp> ‐1

Sophie Bouchat, Nadège Delacourt, Anna Kula,

EMBO Molecular Medicine

2015

84

Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line

Amit Kumar, Wasim Abbas, Laurence Colin,

Scientific Reports

2016

41

Reactivation capacity by latency-reversing agents ex vivo correlates with the size of the HIV-1 reservoir

Gilles Darcis, Sophie Bouchat, Anna Kula,

AIDS

2016

39

Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection

S. Reuse, Laurence Colin, Miriam Calao,

2010

29

Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin Treatments

Anna Kula, Nadège Delacourt, Sophie Bouchat,

JAIDS Journal of Acquired Immune Deficiency Syndromes

2019

29

Novel role of UHRF1 in the epigenetic repression of the latent HIV-1

Roxane Verdikt, Maryam Bendoumou, Sophie Bouchat,

EBioMedicine

2022

24

Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites

Sylvain Fauquenoy, Gwenaëlle Robette, Anna Kula,

Scientific Reports

2017

12

Page 1